ERDERA Clinical Trial Call – Guidelines for Applicants

These guidelines explain the eligibility rules, submission process and Expression of Interest requirements for the ERDERA Clinical Trial Call.

This document sets out the aim, eligibility criteria, application process, and application instructions for the ERDERA Clinical Trial Call (ECTC).  It also explains the sections required for the Expression of Interest, including project data, project description, the coordinating investigator and sponsor, partners, budget, notes, declarations, submission and data protection.

Acces this publication

publication

ERDERA clinical trial call

Year of publication

2026

Author

European Rare Diseases Research Alliance (ERDERA)

You might also be interested in

ERDERA - GAM day 2 - JVDPhotography-65

ERDERA announces its 2026 Open Session

This free online session will highlight patient and research perspectives, innovative clinical study methods, and emerging regulatory approaches
ERDERA trainings template (7)

Regulatory Insights of Advanced Therapies Research & Development

September 30 @ 1:00 pm - 2:00 pm
This ERDERA webinar will provide an overview of the regulatory and ethical requirements for advanced therapy medicinal product (ATMP) research, with a particular focus on genome editing and paediatric studies in rare diseases.
October 2026 (5)

ERDERA’s Open Session – 3rd General Assembly Meeting

October 21 @ 2:30 pm - 5:30 pm
A special anniversary event showcasing how innovation, collaboration and novel trial methodologies are advancing rare disease research.
ERDERA trainings template (9)

The 2027 Open Academy x ERDERA Schools is now open for application

Applications for the 2027 Open Academy x ERDERA Schools offer patient advocates and early-career researchers the opportunity to strengthen their knowledge and participation in rare disease research.

ERDERA Search